Cart
sales@molnova.com
PRLX-93936 HCL
CAS No. 1094210-96-4
PRLX-93936 HCL( —— )
Catalog No. M34837 CAS No. 1094210-96-4
PRLX-93936 HCL is an analog of erastin and demonstrated synergistic effects against non-small cell lung cancer (NSCLC) cells with cisplatin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 353 | In Stock |
|
| 10MG | 534 | In Stock |
|
| 25MG | 845 | In Stock |
|
| 50MG | 1107 | In Stock |
|
| 100MG | 1479 | In Stock |
|
| 200MG | 2018 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePRLX-93936 HCL
-
NoteResearch use only, not for human use.
-
Brief DescriptionPRLX-93936 HCL is an analog of erastin and demonstrated synergistic effects against non-small cell lung cancer (NSCLC) cells with cisplatin.
-
DescriptionPRLX-93936 dihydrochloride (Compound 16) is a HIF-1α inhibitor with anticancer activity. PRLX-93936 can inhibit the activated Ras pathway and can be used in the study of relapsed or refractory multiple myeloma.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetFerroptosis
-
RecptorFerroptosis | Reactive Oxygen Species
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1094210-96-4
-
Formula Weight437.37
-
Molecular FormulaC21H26Cl2N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.CCOc1ccccc1-n1c(CN2CCNCC2)nc2ccccc2c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang W, et al. Synthesis and evaluation of quinazolin-4-ones as hypoxia-inducible factor-1α inhibitors. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5239-43.?
molnova catalog
related products
-
UAMC3203
UAMC-3203 is a potent and selective Ferroptosis inhibitor (IC50: 12 nM).
-
Cerivastatin
Cerivastatin is an orally active and highly effective HMG-CoA reductase inhibitor with anticancer and lipid-lowering effects.
-
MMRi62
MMRi62 (7-[(2,3-dichlorophenyl)-(pyridin-2-ylamino)methyl]quinolin-8-ol), a ferroptosis inducer targeting MDM2-MDM4 (negative regulators of tumor suppressor p53).
